Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Oncol Rep. 2005 Jul;7(4):260-5.

New therapeutic options for mesothelioma.

Author information

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. rkg2@duke.edu

Abstract

Malignant pleural mesothelioma is an aggressive thoracic tumor that is often refractory to chemotherapy and radiotherapy, making long-term survival a difficult goal. Although multimodality therapies, including cytoreductive surgery, chemotherapy, and radiotherapy, have been tested, their survival benefit is unclear. Recently, novel cytotoxic agents such as pemetrexed have shown promise in the treatment of malignant pleural mesothelioma, and in early trials new small-molecule agents targeted to the specific biochemical properties of this tumor have shown promise.

PMID:
15946584
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk